Financial Integrity and Regulation Management Act or the FIRM Act This bill prohibits the consideration of reputational risk by federal banking agencies when regulating, examining, or supervising a depository institution or credit union. The bill defines reputational risk as the potential for negative publicity or public attention to decrease confidence in the institution, lead to litigation, reduce revenues, or result in other adverse impacts to the institution. Agencies must report on the implementation of this bill.
This bill (HR 2199) prevents private health insurance plans from discriminating against patients with end-stage kidney disease (ESRD) who require dialysis. It amends the Social Security Act to prohibit plans from treating dialysis coverage differently than other medical services or applying network restrictions that disproportionately harm ESRD patients. The law clarifies that plans cannot deny or limit benefits for dialysis based on a patient’s diagnosis, while preserving a plan’s right to choose which dialysis providers are in their network. It directly affects ESRD patients and their private health insurance coverage, ensuring dialysis is treated equally with other covered medical services. The bill does not require plans to include specific dialysis providers but stops them from unfairly restricting access to necessary care.
This bill modifies Medicare's physician self-referral rules to improve access for rural communities. It creates a new exemption for "covered rural hospitals" (defined as facilities in rural areas more than 35 miles from another hospital or critical access hospital) from certain restrictions on physicians owning hospitals. The bill also removes a prohibition on expanding existing physician-owned hospitals, allowing such expansions after the law's enactment. These changes directly affect rural hospitals seeking Medicare participation and physicians who own or operate hospitals in underserved areas.
The Air America Act of 2025 authorizes one-time payments of $40,000 to individuals who worked for Air America or its affiliated companies for at least five years during 1950-1976, or to their surviving spouses, children, or dependents. Additional payments of $8,000 per full year beyond five years are allowed. The program is capped at $60 million total funding, with claims required within two years of final regulations. Payments are a single lump sum with no ongoing benefits, and the bill explicitly states it does not create new entitlements beyond this one-time award.
HR 2222, the "Lowering Egg Prices Act of 2025," modifies federal egg regulations to allow surplus broiler hatching eggs (used to hatch chicks for meat production) to be sold to egg breakers (facilities that process whole eggs into liquid products). The bill directs the FDA and USDA to create new rules within 180 days permitting these eggs to be stored under conditions compatible with hatching while also being sold for processing into liquid egg products. This change aims to increase the supply of eggs available for processing by making it easier to redirect surplus hatching eggs to egg breakers. The bill directly affects broiler hatcheries, egg breakers, and the broader egg processing industry by altering how certain surplus eggs can be handled and sold.
HR 2202 prohibits federal funds from being used for gender transition procedures or health plans covering them in federal programs like Medicaid and the Affordable Care Act. It does not ban these procedures but restricts federal subsidies, requiring individuals to pay for such coverage using non-federal funds (e.g., out-of-pocket or private insurance not tied to federal programs). The bill defines gender transition procedures broadly to include hormonal treatments and surgeries (e.g., mastectomy, hysterectomy), with exceptions for medically necessary treatments related to disorders of sex development or complications from such procedures. It also clarifies that ACA premium tax credits and cost-sharing reductions cannot apply to plans covering these procedures, though separate non-federal-funded coverage remains an option.
This bill protects pregnancy centers that provide non-abortion services from federal discrimination. It prohibits government entities and recipients of federal funds from forcing these centers to offer, refer for, or promote abortions, or from restricting their life-affirming services like pregnancy testing, counseling, or baby supplies. The law creates a legal path for affected centers to sue if they face retaliation for declining abortion-related activities. It amends federal health law to explicitly shield such organizations from being penalized for their stance.
HR 2197, the "No 340B Savings for Transgender Care Act," prohibits covered entities participating in the federal 340B drug pricing program from using savings from discounted drug purchases to pay for specific transgender healthcare services. The bill amends the Public Health Service Act to ban using 340B savings for sex reassignment surgeries or hormone treatments provided "for the purpose of gender alteration" of transgender individuals. This directly affects hospitals and clinics enrolled in the 340B program, restricting how they allocate funds saved through the program’s discounted drug pricing. The key provision is a targeted restriction on fund usage, not a ban on providing the medical services themselves. The bill focuses on reallocating program savings away from these specific care types.
This bill amends the tax code to permanently establish a 7-year depreciation period for motorsports entertainment complexes, replacing a temporary provision. It directly affects businesses operating these facilities by allowing them to deduct the cost of qualifying assets over seven years instead of a shorter period. The key change is removing a temporary rule (subparagraph D) from the tax code, making the longer recovery period permanent for these specific properties. The bill focuses solely on clarifying and extending this tax treatment without additional policy changes.
This bill repeals federal waivers that allow California to set its own vehicle and engine emission standards under the Clean Air Act. It directly affects California's Air Resources Board (CARB), prohibiting the state from adopting or enforcing standards for nonroad engines (like construction equipment, farm vehicles, and locomotives) or new motor vehicles. Key provisions include removing federal authorization for California's vehicle standards (Section 177) and invalidating all existing waivers for state emission rules. The bill would eliminate California's ability to enforce its own emission requirements for these categories, shifting authority entirely to federal standards.
HR 2125, the SOS Act of 2025, establishes a 15-member National Commission on the Maritime Industrial Base (the "SOS Commission") to study the state of the U.S. maritime industry. The Commission will investigate shipyard conditions, military shipbuilding needs, workforce adequacy, and regulatory challenges, with a focus on national defense and job preservation. It must submit a report with policy recommendations to the President and Congress within one year of its first meeting. The bill does not enact new policies but creates a mechanism for evaluating the maritime sector to inform future decisions.
The Stop CCP VISAs Act of 2025 would prohibit U.S. visas for Chinese citizens seeking to study or conduct research in the United States. It specifically blocks the issuance of F-1 (academic student), J-1 (exchange visitor), and M-1 (vocational student) visas for these purposes. This bill directly affects Chinese nationals who otherwise qualify for these student visa categories at U.S. educational institutions. The policy change would amend immigration law to implement this visa ban.
